EWM
Essex Woodlands Management Portfolio holdings
AUM $279M
1-Year Return
29.39%
This Quarter Return
+1.84%
1 Year Return
+29.39%
3 Year Return
+195.65%
5 Year Return
+90.32%
10 Year Return
+273.6%
AUM
$214M
AUM Growth
+$53.9M
(+34%)
Cap. Flow
+$42.6M
Cap. Flow
% of AUM
19.86%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
2
Increased
–
Reduced
1
Closed
–
Top Buys
| 1 |
Venus Concept
VERO
|
+$33M |
| 2 |
TELA Bio
TELA
|
+$9.96M |
Top Sells
| 1 |
MediciNova
MNOV
|
+$357K |
Sector Composition
| 1 | Healthcare | 99.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
EyePoint Pharmaceuticals
EYPT
$940M
| $65M | 30.3% |
4,190,922
| – | – |
|
|
RVNC
2
DELISTED
Revance Therapeutics, Inc.
RVNC
| $54.2M | 25.3% |
3,342,047
| – | – |
|
3
Axogen
AXGN
$774M
| $43.5M | 20.28% |
2,429,999
| – | – |
|
|
4
Venus Concept
VERO
$4.39M
| $33M | 15.38% |
+42,532
| New | +$33M |
|
|
5
TELA Bio
TELA
$59.8M
| $9.96M | 4.65% |
+769,231
| New | +$9.96M |
|
|
6
MediciNova
MNOV
$59.8M
| $7.53M | 3.51% |
1,117,355
-53,015
| -5% | -$357K |
|
|
ELGX
7
DELISTED
Endologix Inc
ELGX
| $717K | 0.33% |
125,747
| – | – |
|
8
Gyre Therapeutics
GYRE
$685M
| $535K | 0.25% |
10,483
| – | – |
|